tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Zynex (ZYXI) and Edesa Biotech (EDSA)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BioNTech SE (BNTXResearch Report), Zynex (ZYXIResearch Report) and Edesa Biotech (EDSAResearch Report) with bullish sentiments.

BioNTech SE (BNTX)

H.C. Wainwright analyst Robert Burns reiterated a Buy rating on BioNTech SE today and set a price target of $366.00. The company’s shares closed last Monday at $231.85.

According to TipRanks.com, Burns has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -12.6% and a 25.9% success rate. Burns covers the Healthcare sector, focusing on stocks such as Forma Therapeutics Holdings, Turning Point Therapeutics, and Black Diamond Therapeutics.

Currently, the analyst consensus on BioNTech SE is a Moderate Buy with an average price target of $299.58, a 18.0% upside from current levels. In a report issued on December 22, Kempen & Co also upgraded the stock to Buy with a $350.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Zynex (ZYXI)

In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Zynex, with a price target of $22.00. The company’s shares closed last Monday at $10.29, close to its 52-week low of $9.30.

According to TipRanks.com, Chen is a 5-star analyst with an average return of 27.3% and a 40.9% success rate. Chen covers the Healthcare sector, focusing on stocks such as Ortho Clinical Diagnostics Holdings, Interpace Diagnostics Group, and HTG Molecular Diagnostics.

Zynex has an analyst consensus of Moderate Buy, with a price target consensus of $16.83, a 66.3% upside from current levels. In a report issued on December 27, B.Riley Financial also maintained a Buy rating on the stock with a $15.50 price target.

Edesa Biotech (EDSA)

In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Edesa Biotech, with a price target of $16.00. The company’s shares closed last Monday at $5.97.

According to TipRanks.com, Bernardino is a 5-star analyst with an average return of 28.9% and a 35.5% success rate. Bernardino covers the Healthcare sector, focusing on stocks such as Aridis Pharmaceuticals, Eledon Pharmaceuticals, and Achieve Life Sciences.

Currently, the analyst consensus on Edesa Biotech is a Moderate Buy with an average price target of $16.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on BNTX:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed